These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 8629631)
1. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients. Sennesael JJ; Lamote JG; Violet I; Tasse S; Verbeelen DL Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631 [TBL] [Abstract][Full Text] [Related]
2. Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients. Sennesael J; Lamote J; Violet I; Tasse S; Verbeelen D Hypertension; 1995 Sep; 26(3):436-44. PubMed ID: 7649579 [TBL] [Abstract][Full Text] [Related]
3. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors. Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523 [TBL] [Abstract][Full Text] [Related]
4. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies. Pedersen EB; Madsen JK; Sørensen SS; Zachariae H Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522 [TBL] [Abstract][Full Text] [Related]
5. Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A. Hansen JM; Fogh-Andersen N; Leyssac PP; Strandgaard S Nephron; 1998 Dec; 80(4):450-7. PubMed ID: 9832645 [TBL] [Abstract][Full Text] [Related]
6. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients. Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569 [TBL] [Abstract][Full Text] [Related]
7. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related]
8. Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone. Madsen JK; Kornerup HJ; Pedersen EB Scand J Clin Lab Invest; 1995 Nov; 55(7):625-33. PubMed ID: 8633187 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study. Ruilope LM; Schaefer A Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342 [TBL] [Abstract][Full Text] [Related]
10. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation. Madsen JK; Sørensen SS; Hansen HE; Pedersen EB Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517 [TBL] [Abstract][Full Text] [Related]
11. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868 [TBL] [Abstract][Full Text] [Related]
12. Hypertension after renal transplantation. Calcium channel or converting enzyme blockade? van der Schaaf MR; Hené RJ; Floor M; Blankestijn PJ; Koomans HA Hypertension; 1995 Jan; 25(1):77-81. PubMed ID: 7843758 [TBL] [Abstract][Full Text] [Related]
13. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647 [TBL] [Abstract][Full Text] [Related]
14. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients. Hartmann A; Andereassen AK; Holdaas H; Simonsen S; Geiran O; Berg KJ J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913 [TBL] [Abstract][Full Text] [Related]
15. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA. Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912 [TBL] [Abstract][Full Text] [Related]
16. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy. Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765 [TBL] [Abstract][Full Text] [Related]
17. Glomerulotubular function in long-term renal allograft recipients. A comparison of conventional therapy with cyclosporine. Propper DJ; Whiting PH; Mackay J; Catto GR Transplantation; 1990 Jul; 50(1):72-5. PubMed ID: 2368153 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats. Nakamura Y; Ono H; Frohlich ED Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453 [TBL] [Abstract][Full Text] [Related]